Xuzhe Zhao

No.119 South Fourth Ring West Road
Fengtai, 100070, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Isocitrate Dehydrogenase Wild-type Glioblastoma Resection Under Fluorescein Sodium and White Light Guidance Based on Response Assessment in Neuro-Oncology Resect Criteria: Fluorescein Significantly Enhances Complete Resection Rate of Enhanced Tumors.

Isocitrate Dehydrogenase Wild-type Glioblastoma Resection Under Fluorescein Sodium and White Light Guidance Based on Response Assessment in Neuro-Oncology Resect Criteria: Fluorescein Significantly Enhances Complete Resection Rate of Enhanced Tumors.

Journal: Operative neurosurgery (Hagerstown, Md.)

Published: January 12, 2025

Prognostic and clinical significance of contrast enhancement in WHO grade 2 oligodendrogliomas.

Prognostic and clinical significance of contrast enhancement in WHO grade 2 oligodendrogliomas.

Journal: Journal of neuro-oncology

Published: November 23, 2024

Heat shock proteins related signature characterizes immune status and predicts prognosis of gliomas.

Heat shock proteins related signature characterizes immune status and predicts prognosis of gliomas.

Journal: Scientific reports

Published: September 18, 2024

Sublethal laser interstitial thermal therapy leads to confined neurological deficits and glioblastoma regression.

Sublethal laser interstitial thermal therapy leads to confined neurological deficits and glioblastoma regression.

Journal: Lasers in medical science

Published: September 16, 2024

Toll-like receptor agonists promote the formation of tertiary lymphoid structure and improve anti-glioma immunity.

Toll-like receptor agonists promote the formation of tertiary lymphoid structure and improve anti-glioma immunity.

Journal: Neuro-oncology

Published: August 27, 2024

MR‑guided laser interstitial thermal therapy followed by early application of temozolomide for recurrent IDH-wildtype glioblastomas: preliminary results from a prospective study.

MR‑guided laser interstitial thermal therapy followed by early application of temozolomide for recurrent IDH-wildtype glioblastomas: preliminary results from a prospective study.

Journal: Neurosurgical review

Published: August 14, 2024

New hopes and challenges in targeted therapy and immunotherapy for primary central nervous system lymphoma.

New hopes and challenges in targeted therapy and immunotherapy for primary central nervous system lymphoma.

Journal: Frontiers in immunology

Published: May 24, 2024

Unveiling hierarchy and spatial distribution of O6-methylguanine-DNA methyltransferase promoter methylation in World Health Organization grade 2-3 gliomas.

Unveiling hierarchy and spatial distribution of O6-methylguanine-DNA methyltransferase promoter methylation in World Health Organization grade 2-3 gliomas.

Journal: Cancer science

Published: March 30, 2024

Subventricular zone-associated classification in isocitrate dehydrogenase-wildtype glioblastomas: improved prognostic value through integration of FLAIR with contrast-enhanced imaging.

Subventricular zone-associated classification in isocitrate dehydrogenase-wildtype glioblastomas: improved prognostic value through integration of FLAIR with contrast-enhanced imaging.

Journal: Journal of neurosurgery

Published: November 16, 2023

Laser interstitial thermal therapy for recurrent glioblastomas: a systematic review and meta-analysis.

Laser interstitial thermal therapy for recurrent glioblastomas: a systematic review and meta-analysis.

Journal: Neurosurgical review

Published: August 17, 2023

Characterization and clinical implications of different malignant transformation patterns in diffuse low-grade gliomas.

Characterization and clinical implications of different malignant transformation patterns in diffuse low-grade gliomas.

Journal: Cancer science

Published: March 31, 2023

A prognostic estimation model based on mRNA-sequence data for patients with oligodendroglioma.

A prognostic estimation model based on mRNA-sequence data for patients with oligodendroglioma.

Journal: Frontiers in neurology

Published: October 19, 2022

Showing 1-12 of 24

Last Updated: 09/26/2026